Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

636
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
636
Brain Imaging01:14

Brain Imaging

835
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
835

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct brain volume changes associated with the head-turning sign and Neucop-Q response patterns in Alzheimer's disease.

Journal of Alzheimer's disease reports·2026
Same author

Author Correction: Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets.

Nature medicine·2025
Same author

Identification and characterization of the thalamic ventral posterior complex by 11.7T ex vivo diffusion tensor imaging.

Brain structure & function·2025
Same author

Quantification of perforant path fibers for early detection of Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

OpenMAP-T1: A Rapid Deep-Learning Approach to Parcellate 280 Anatomical Regions to Cover the Whole Brain.

Human brain mapping·2024
Same author

Microstructural Neurodegeneration of the Entorhinal-Hippocampus Pathway along the Alzheimer's Disease Continuum.

Journal of Alzheimer's disease : JAD·2023
Same journal

[Neuropathological Autopsies in Japan: Current Scenario and Challenges].

Brain and nerve = Shinkei kenkyu no shinpo·2026
Same journal

[Telemedicine and Digital Technologies in Neurological Intractable Diseases].

Brain and nerve = Shinkei kenkyu no shinpo·2026
Same journal

[Disaster Countermeasures for Intractable Neurological Disease].

Brain and nerve = Shinkei kenkyu no shinpo·2026
Same journal

[Supporting Health Care Transition for Patients with Childhood-Onset Chronic Conditions: Within Intractable Disease Care in Japan].

Brain and nerve = Shinkei kenkyu no shinpo·2026
Same journal

[Multidisciplinary Collaboration between Hospitals and Clinics at the University Hospital and the Core Hospital for the Treatment of Intractable Diseases].

Brain and nerve = Shinkei kenkyu no shinpo·2026
Same journal

[The Role of Coordinators for Intractable Diseases in Japan].

Brain and nerve = Shinkei kenkyu no shinpo·2026
See all related articles

Related Experiment Video

Updated: Mar 11, 2026

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.4K

[Imaging Analysis and Dementia Screening].

Susumu Mori1

  • 1Department of Radiology, Johns Hopkins University School of Medicine.

Brain and Nerve = Shinkei Kenkyu No Shinpo
|March 10, 2026
PubMed
Summary
This summary is machine-generated.

Dementia screening aims for early detection and intervention, utilizing various indicators like cognitive tests and biomarkers. Integrating multiple markers is key due to the lack of a single robust preclinical indicator.

More Related Videos

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.0K
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

8.5K

Related Experiment Videos

Last Updated: Mar 11, 2026

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

22.4K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.0K
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

8.5K

Area of Science:

  • Neurology
  • Gerontology
  • Public Health

Background:

  • Dementia screening is crucial for early detection and preventive interventions.
  • Distinguishing screening from diagnostic assessment is vital for appropriate patient pathways.

Purpose of the Study:

  • To clarify the concept of dementia screening.
  • To examine the current status and challenges of dementia screening methods.

Main Methods:

  • Review of current dementia screening indicators.
  • Analysis of cognitive tests, neuroimaging (MRI, PET), blood biomarkers, and genetic factors.
  • Assessment of challenges in preclinical dementia detection.

Main Results:

  • No single robust biomarker exists for the preclinical stage of dementia.
  • Integration of multiple, modestly discriminative indicators is essential for effective screening.
  • Current screening methods face challenges in identifying preclinical dementia.

Conclusions:

  • Future dementia screening models should be low-cost.
  • Leveraging large datasets (e.g., Japan's brain dock) and advanced blood tests can improve screening.
  • Developing integrated, multi-modal screening approaches is a promising direction.